California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$78.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DNLI Denali Therapeutics Inc.	$1.77B	$1.6 Million 0.0% of portfolio	117,535	Q1 2025 Reduced 2.2%
ARQT Arcutis Biotherapeutics, Inc.	$887M	$1.53 Million 0.0% of portfolio	97,682	Q1 2025 Reduced 0.87%
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$1.48 Million 0.0% of portfolio	32,808	Q1 2025 Reduced 2.85%
AGIO Agios Pharmaceuticals, Inc.	$1.94B	$1.38 Million 0.0% of portfolio	46,988	Q1 2025 Reduced 2.63%
BCRX Biocryst Pharmaceuticals Inc	$1.55B	$1.34 Million 0.0% of portfolio	179,143	Q1 2025 Reduced 2.9%
IDYA Ideaya Biosciences, Inc.	$1.13B	$1.33 Million 0.0% of portfolio	81,278	Q1 2025 Added 13.32%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.88B	$1.31 Million 0.0% of portfolio	102,675	Q1 2025 Reduced 2.36%
APLS Apellis Pharmaceuticals, Inc.	$2.63B	$1.31 Million 0.0% of portfolio	59,778	Q1 2025 Reduced 15.43%
TARS Tarsus Pharmaceuticals, Inc.	$1.37B	$1.3 Million 0.0% of portfolio	25,364	Q1 2025 Reduced 1.09%
TVTX Travere Therapeutics, Inc.	$1.12B	$1.29 Million 0.0% of portfolio	72,192	Q2 2024 Reduced 6.68%
MNKD Mannkind Corp	$942M	$1.29 Million 0.0% of portfolio	256,727	Q2 2024 Added 2.89%
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$1.23 Million 0.0% of portfolio	37,087	Q2 2024 Reduced 18.03%
RXRX Recursion Pharmaceuticals, Inc.	$976M	$1.22 Million 0.0% of portfolio	230,167	Q1 2025 Reduced 0.59%
ARDX Ardelyx, Inc.	$866M	$1.08 Million 0.0% of portfolio	220,159	Q2 2024 Added 3.27%
CLDX Celldex Therapeutics, Inc.	$1.11B	$1.02 Million 0.0% of portfolio	56,170	Q2 2024 Added 1.75%
KYMR Kymera Therapeutics, Inc.	$2.18B	$1.01 Million 0.0% of portfolio	36,839	Q2 2024 Added 21.33%
JANX Janux Therapeutics, Inc.	$1.01B	$991,000 0.0% of portfolio	36,735	Q2 2024 Reduced 43.55%
VERA Vera Therapeutics, Inc.	$572M	$976,000 0.0% of portfolio	40,640	Q2 2024 Reduced 14.22%
INVA Innoviva, Inc.	$1.4B	$952,000 0.0% of portfolio	52,562	Q2 2024 Added 5.59%
AUPH Aurinia Pharmaceuticals Inc.	$1.61B	$921,000 0.0% of portfolio	114,591	Q2 2024 Added 17.58%
SNDX Syndax Pharmaceuticals Inc	$734M	$885,000 0.0% of portfolio	72,019	Q2 2024 Added 4.62%
NVAX Novavax Inc	$663M	$868,000 0.0% of portfolio	135,486	Q2 2024 Reduced 8.36%
MDXG Mimedx Group, Inc.	$821M	$835,000 0.0% of portfolio	109,927	Q2 2024 Added 4.75%
NRIX Nurix Therapeutics, Inc.	$472M	$795,000 0.0% of portfolio	66,994	Q1 2025 Added 28.02%
WVE Wave Life Sciences Ltd.	$734M	$793,000 0.0% of portfolio	98,237	Q2 2024 Reduced 20.84%
EWTX Edgewise Therapeutics, Inc.	$846M	$792,000 0.0% of portfolio	36,028	Q1 2025 Reduced 4.28%
GERN Geron Corp	$510M	$771,000 0.0% of portfolio	484,962	Q2 2024 Reduced 14.54%
LQDA Liquidia Corp	$1.55B	$765,000 0.0% of portfolio	51,928	Q2 2024 Reduced 5.92%
ETNB 89bio, Inc.	$420M	$755,000 0.0% of portfolio	103,977	Q1 2025 Added 35.17%
MLTX Moon Lake Immunotherapeutics	$2.04B	$741,000 0.0% of portfolio	18,972	Q2 2024 Reduced 24.92%
VRDN Viridian Therapeutics, Inc.\De	$717M	$737,000 0.0% of portfolio	54,710	Q2 2024 Reduced 13.68%
ADPT Adaptive Biotechnologies Corp	$1.81B	$723,000 0.0% of portfolio	97,388	Q2 2024 Reduced 91.38%
IOVA Iovance Biotherapeutics, Inc.	$352M	$676,000 0.0% of portfolio	203,241	Q2 2024 Reduced 3.97%
OCUL Ocular Therapeutix, Inc	$961M	$674,000 0.0% of portfolio	91,998	Q2 2024 Added 10.96%
AVXL Anavex Life Sciences Corp.	$840M	$672,000 0.0% of portfolio	78,352	Q1 2025 Added 1,326.4%
NTLA Intellia Therapeutics, Inc.	$825M	$644,000 0.0% of portfolio	90,638	Q2 2024 Reduced 0.87%
XNCR Xencor Inc	$463M	$629,000 0.0% of portfolio	59,130	Q2 2024 Reduced 8.35%
DYN Dyne Therapeutics, Inc.	$602M	$561,000 0.0% of portfolio	53,635	Q2 2024 Added 1.66%
VIR Vir Biotechnology, Inc.	$578M	$539,000 0.0% of portfolio	83,197	Q2 2024 Added 10.62%
EYPT Eye Point Pharmaceuticals, Inc.	$366M	$492,000 0.0% of portfolio	90,879	Q1 2025 Added 86.94%
ABUS Arbutus Biopharma Corp	$510M	$463,000 0.0% of portfolio	132,758	Q2 2024 Reduced 92.39%
DAWN Day One Biopharmaceuticals, Inc.	$451M	$439,000 0.0% of portfolio	55,470	Q2 2024 Reduced 14.58%
RCKT Rocket Pharmaceuticals, Inc.	$220M	$424,000 0.0% of portfolio	63,637	Q2 2024 Reduced 2.38%
REPL Replimune Group, Inc.	$259M	$416,000 0.0% of portfolio	42,725	Q2 2024 Reduced 0.37%
PRTA Prothena Corp Public LTD CO	$354M	$411,000 0.0% of portfolio	33,243	Q2 2024 Added 4.59%
IBRX Immunity Bio, Inc.	$989M	$393,000 0.0% of portfolio	130,668	Q2 2024 Added 1.18%
RCUS Arcus Biosciences, Inc.	$698M	$371,000 0.0% of portfolio	47,341	Q2 2024 Added 3.99%
NUVB Nuvation Bio Inc.	$504M	$352,000 0.0% of portfolio	200,380	Q2 2024 Reduced 32.43%
COGT Cogent Biosciences, Inc.	$760M	$351,000 0.0% of portfolio	58,649	Q2 2024 Added 7.32%
CRMD Cor Medix Inc.	$474M	$349,000 0.0% of portfolio	56,675	Q1 2025 Added 1,172.17%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.